The University of Queensland

mFOLFIRINOX And STEreotactic body Radiotherapy (SBRT) for Pancreatic cancer with high-risk and Locally AdvaNced disease (MASTERPLAN)...(MRFF LSCD administered by The University of Sydney) (2019–2024)

Grant type:

University of Sydney

Researchers:

• 

  Professor Andrew Barbour

  Professor
  

  Princess Alexandra Hospital Southside Clinical Unit

  Faculty of Medicine

Funded by:

The University of Sydney